tirzepatide cvs caremark adds Zepbound back to preferred coverage CVS Caremark drops Zepbound coverage

Patients using Wegovy often report significant reductions in body weight, with clinical trials showing an average weight loss of around 15% of their initial body weight

Rare (may affect up to 1 in 1 000 people) severe allergic reactions (anaphylactic reactions, angioedema)

Better growth hormone signalling means deeper, more restorative sleep cycles

Three critical warning signs that require immediate attention: Persistent gastrointestinal symptoms Vomiting or diarrhea lasting more than 48 hours, potentially leading to dangerous dehydration Severe abdominal pain Particularly in the upper abdomen, which may indicate pancreatitis, a serious complication Allergic reactions Including difficulty breathing, facial swelling, or widespread rash The distinction often lies in intensity and duration